- Home
- WAFU vs KTTA Comparison
WAFU vs KTTA Comparison
Compare WAFU & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- KTTA
- Stock Information
- Founded
- WAFU 1999
- KTTA 2020
- Country
- WAFU China
- KTTA United States
- Employees
- WAFU N/A
- KTTA N/A
- Industry
- WAFU Other Consumer Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- KTTA Health Care
- Exchange
- WAFU Nasdaq
- KTTA Nasdaq
- Market Cap
- WAFU 6.5M
- KTTA 5.5M
- IPO Year
- WAFU 2019
- KTTA 2021
- Fundamental
- Price
- WAFU N/A
- KTTA N/A
- Analyst Decision
- WAFU
- KTTA
- Analyst Count
- WAFU 0
- KTTA 0
- Target Price
- WAFU N/A
- KTTA N/A
- AVG Volume (30 Days)
- WAFU 263.8K
- KTTA 95.5K
- Earning Date
- WAFU 01-01-0001
- KTTA 11-12-2025
- Dividend Yield
- WAFU N/A
- KTTA N/A
- EPS Growth
- WAFU N/A
- KTTA N/A
- EPS
- WAFU N/A
- KTTA N/A
- Revenue
- WAFU $6,186,645.00
- KTTA N/A
- Revenue This Year
- WAFU N/A
- KTTA N/A
- Revenue Next Year
- WAFU N/A
- KTTA N/A
- P/E Ratio
- WAFU N/A
- KTTA N/A
- Revenue Growth
- WAFU N/A
- KTTA N/A
- 52 Week Low
- WAFU $1.22
- KTTA $0.65
- 52 Week High
- WAFU $7.49
- KTTA $5.06
- Technical
- Relative Strength Index (RSI)
- WAFU 63.32
- KTTA 61.03
- Support Level
- WAFU $1.92
- KTTA $0.70
- Resistance Level
- WAFU $2.17
- KTTA $0.81
- Average True Range (ATR)
- WAFU 0.13
- KTTA 0.03
- MACD
- WAFU 0.01
- KTTA 0.01
- Stochastic Oscillator
- WAFU 58.00
- KTTA 80.40
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).